Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis.

Yong-Bum ParkFrancesco BonellaNobert BlankGabriela RiemekastenUlf Müller-LadnerJörg HenesElise SiegertClaudia GüntherIna KötterChristiane PfeifferMarc SchmalzingGabriele ZeidlerPeter KorstenLaura SusokAaron JucheMargitta WormIlona JandovaJan EhrchenCord SunderkötterGernot KeyßerAndreas RammingTim SchmeiserAlexander KreuterKathrin KuhrHanns-Martin LorenzPia MoinzadehNicolas Hunzelmann

Published in: Rheumatology (Oxford, England) (2023)

GERD had no effect on survival in SSc or SSc-ILD. PPIs improved survival in patients with SSc-ILD. Controlled, prospective trials are needed to confirm this finding.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
free survival
stem cells
replacement therapy
chemotherapy induced